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Health solu ons for the poor VOL Setting: Three regional referral hospitals in Uganda with a high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) cases. Objective: To determine the treatment outcomes of TB retreatment cases and factors influencing these outcomes.
Design: A retrospective cohort study of routinely collected National Tuberculosis Programme data between 1 January 2009 and 31 December 2010. Results: The study included 331 retreatment patients (68% males), with a median age of 36 years, 93 (28%) of whom were relapse smear-positive, 21 (6%) treatment after failure, 159 (48%) return after loss to follow-up, 26 (8%) relapse smear-negative and 32 (10%) relapse cases with no smear performed. Treatment success rates for all categories of retreatment cases ranged between 28% and 54%. Relapse smear-positive (P = 0.002) and treatment after failure (P = 0.038) cases were less likely to have a successful treatment outcome. Only 32% of the retreatment cases received a Category II treatment regimen; there was no difference in treatment success among patients who received Category II or Category I treatment regimens (P = 0.73). Conclusion: Management of TB retreatment cases and treatment success for all categories in three referral hospitals in Uganda was poor. Relapse smear-positive or treatment after failure cases were less likely to have a successful treatment outcome.
T he management of previously treated tuberculosis (TB) patients (retreatment cases) is a challenge for National Tuberculosis Programmes (NTPs) in resourcelimited settings such as Uganda, which ranks among the 22 high TB burden countries. 1 From 2009 to 2012, 7.0-7.5% of all TB cases in Uganda were reported to the World Health Organization (WHO) as retreatment cases. [1] [2] [3] [4] WHO case defi nitions for retreatment cases include relapse smear-positive, treatment after failure, return after loss to follow-up (LTFU) and retreatment other. 5 Studies from India and Africa have shown that retreatment, failure and return after LTFU cases have poor treatment outcomes, with success rates of 50-60%. [6] [7] [8] [9] Patient characteristics such as male sex, alcoholism and illiteracy, and health system factors such as long distances to TB clinics, lack of anti-tuberculosis drugs, inadequate health education and poor management of drug side effects are risk factors for return after LTFU or retreatment default. [10] [11] [12] [13] [14] [15] Some studies have identifi ed characteristics of retreatment cases that infl uence
Data collection
Data were sourced from TB health unit registers at the regional referral hospitals and from an electronic database for culture and DST at the NTRL using a structured data form. Variables collected were age, sex, retreatment category, HIV status, being on antiretroviral treatment (ART) or cotrimoxazole preventive therapy (CPT), TB regimen prescribed, number of retreatment cases who received culture and DST and treatment outcomes (cured, completed, failure, interruption, died, transferred out). TB treatment outcomes were based on standard WHO defi nitions. 5 Data validation could not be performed due to lack of access to individual patient TB treatment cards.
Analysis and statistics
Data were double entered by two independent encoders into a fi le using EpiData software version 3.1 (Epi-Data Association, Odense, Denmark). Discordances between the fi les were resolved by cross-checking with the paper forms. The data were analysed using EpiData Analysis version 2.2. Univariate and multivariate analyses were performed to explore characteristics associated with treatment outcomes. Differences between groups were compared using the χ 2 test for categorical variables, with differences at the 5% level regarded as signifi cant.
Ethics approval
Permission to review TB registers and the NTRL database for culture and DST was granted by the Uganda Ministry of Health, the Directors of the regional referral hospitals and the NTRL. Ethics approval was obtained from the International Union Against Tuberculosis and Lung Disease, Paris, Makerere University College of Health Sciences, Kampala, and the Uganda National Council for Science and Technology, Kampala, Uganda.
RESULTS

Demographic and clinical characteristics of retreatment patients
Of 331 retreatment patients, 58 (18%) were from the Gulu, 116 (35%) from the Mbale and 157 (47%) from the Mbarara regional referral hospitals. The demographic and clinical characteristics stratifi ed by r etreatment category are shown in Table 1 . Overall, 224 (68%) were males and the median age was 36 years (interquartile range [IQR] 30-44). The most common retreatment category was return after LTFU (n = 159, 48%), followed by relapse smear-positive cases (n = 93, 28%); 188 (57%) retreatment cases were HIV-positive.
Culture and DST
The Figure shows the proportion of sputum samples sent to the NTRL for DST and culture and what proportion underwent these tests. Of the 29 sputum samples received by the NTRL, the majority were for treatment after failure cases (n = 12, 41%) and relapse smear-negative or relapse cases with no smear testing performed (n = 12, 41%). No culture growth was observed in 10 (35%) samples. DST was performed on 18 (62%) samples, for which results were recorded for 89% (16/18) .
Among the 114 patients registered as relapse smearpositive or treatment after failure, 15 (13%) had sputum samples sent to the NRTL for culture and DST.
Treatment outcomes
TB treatment outcomes according to the characteristics of the retreatment cases are shown in Table 2 . Among the 331 retreatment cases, 180 (54%) had a treatment outcome registered in the health unit register; 94 (28%) cases were transferred out and 57 (17%) had no record of outcome in the register.
Treatment success rates (patients who were cured or completed treatment) were 54% (n = 50/93) for relapse 
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Treatment outcomes of TB retreatment cases 151 smear-positive cases, 48% (n = 10/21) for treatment after failure, 31% (n = 50/159) for return after LTFU, 38% (n = 10/26) for relapse smear-negative and 28% (n = 9/32) for relapse cases with no smear performed.
Although the Category II regimen is recommended by the WHO and the NTP for retreatment cases, only 105 (32%) patients received it. Seventy (21%) patients continued to receive the Category I regimen, 155 (47%) received other regimens that were neither Category I nor II, and 1 (0.3%) patient had no record of the treatment regimen. The treatment success rate among the retreatment cases on the Category II regimen was 46% (n = 48/105); it was 47% (n = 33/70) for those on Category I and 31% (n = 48/155) among those who received neither Category I nor II treatment. Treatment success among those receiving ART was 46% (n = 34/73), 39% (n = 16/41) for those not on ART and 17% (36/217) among those with no record of being on ART.
Patients who did not have a record of treatment outcome (n = 57) were excluded from the risk factor analysis. Patients whose HIV, ART or CPT status was unknown, and those on neither
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the Category I nor the Category II treatment regimens were also excluded from further analysis. Bivariate analysis of retreatment cases showed that relapse smear-positive (P = 0.009), return after LTFU (P = 0.006) and HIV status (P = 0.045) were signifi cantly associated with treatment success; other categories of retreatment cases (P ⩾ 0.05), sex (P = 0.19), age (P = 0.09), ART (P = 0.26) and CPT (P = 0.48) were not. There was no difference in treatment success among patients who received the Category II or Category I regimen (P = 0.73; Table 3 ). The results of logistic regression (Table 4) show that relapse smear-positive cases had a 59% lower chance of treatment success (odds ratio [OR] 0.41, 95% confi dence interval [CI] 0.23-0.73, P = 0.002), while treatment after failure cases had a 72% lower chance of treatment success than other categories of retreatment cases (OR 0.28, 95%CI 0.08-0.93, P = 0.038). Return after LTFU and HIV status were not signifi cantly associated with treatment outcome.
DISCUSSION
This fi rst in-depth study of retreatment cases in Uganda reveals issues regarding their management that may be cause for concern. Very few retreatment cases underwent culture and DST, and treatment success rates for the different categories were low, ranging between 28% and 54%. These fi ndings suggest a number of operational challenges that have to be addressed if the management of retreatment cases is to improve.
The return after LTFU category formed the largest number of retreatment cases. This is contrary to reports from the NTPs in Malawi and Zimbabwe, 8, 18 where relapse smear-positive cases and smear-negative 'others' contributed the highest number of retreatment cases. In Uganda, this fi nding indicates a weak follow-up system for new TB patients on treatment, and calls for strategies to strengthen it.
Half of the retreatment cases were HIV-positive, a similar proportion to new TB patients in Uganda. 1 Despite a WHO policy of culture and DST for all retreatment cases, together with Uganda's policy of culture and DST for smear-positive retreatment cases, fewer than 15% of smear-positive cases in the three study hospitals had sputum specimens sent to the NTRL for culture and DST, highly compromising the quality of their care. Delays in diagnosis and treatment of MDR-TB increase the risk of mortality and expose the communities where these patients reside to MDR-TB strains. This situation continues to hamper global and national efforts to control MDR-TB.
The study also highlights problems in submitting sputum samples from health facilities to the NTRL. At health facilities, clinicians may have inadequate knowledge about the management of retreatment cases, and consequently may not request culture and DST. There may be problems in the transport system, such as the long distances to the pickup points, lack of transport funds and loss of samples between health facilities and the NTRL. Decentralising culture and DST services, along with education of local health staff, would help to increase the number of retreatment cases who receive culture and DST.
It is worth noting that only one third of retreatment cases received the recommended Category II regimen. A similar fi nding was observed in Malawi, 9 where 38% of smear-negative 'other' TB cases received the Category II regimen and 51% received Category I. This fi nding indicates a lack of knowledge of or adherence to national guidelines that could be addressed by training clinicians.
The high transfer-out rate could be explained by the return of referred patients to their home health facilities to continue treatment after a diagnosis of TB. This situation is worsened by a weak follow-up system for these patients. Although the receiving health facilities are responsible for reporting patient treatment outcomes to the referring facilities, this communication is failing. Missing outcomes in the registers could be due to heavy workload and low staffi ng levels at the health facilities, leading to failure to update the registers. Regular support and supervision could help to identify and address these problems.
Treatment success rates were low for the different categories of retreatment cases: relapse smear-positive cases had better treatment outcomes than other categories, in line with studies conducted in Malawi and Zimbabwe, 8, 18 but contrary to a study in India, 19 which showed that 'retreatment other' (including patients with smear-negative TB) had better treatment outcomes than patients with smear-positive TB. The low success rate among the 'relapse no smear done' category may be related to their being treated for other conditions, as TB was not bacteriologically confi rmed.
The study shows that relapse smear-positive and treatment 
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Treatment outcomes of TB retreatment cases 153 after failure cases were less likely to have a successful treatment outcome. Such cases were likely to develop MDR-TB following previous treatment, [20] [21] [22] and were therefore less likely to have a successful outcome. Treatment success did not differ by HIV status, a fi nding similar to a study from Zimbabwe. 18 However, contrary to fi ndings from other studies, 23,24 treatment success among patients who received ART were not different from those who did not receive ART. The same was observed regarding the infl uence of CPT on treatment outcomes. This lack of differences could be explained by the small patient numbers, which did not give enough power to detect a statistically signifi cant difference. Treatment success rates were not different for groups that received the Category I or II regimens. This could be explained by the similarity of the two regimens, which consist of the same antituberculosis drugs except for the addition of streptomycin in the Category II regimen.
A strength of this study was that the three hospitals had a large number of retreatment cases and nearly all of the results were recorded. Another strength was that the study was carried out under routine programme conditions, increasing the likelihood that the NTP management will accept and utilise the fi ndings to improve policy and practice with regard to management of retreatment cases.
Limitations of the study included the fact that only three hospitals were studied, and the results may not be generalisable to the whole country. Missing data in the TB health unit registers and the NTRL electronic database made it diffi cult to ensure completeness of data capture. No copies of the patient's TB treatment card were available at the health facilities to validate the information in the registers, making it diffi cult to ascertain the accuracy of information recorded in the register. Although the WHO classifi es retreatment cases with smear-negative TB or no smear done cases under the category 'other', in this study these categories were analysed separately and included relapse smear-negative and relapse cases with no smear done. This is because they were recorded that way in the TB registers and it was felt important to analyse them separately to enable the NTP to respond appropriately to the problems affecting the different categories. However, a limitation is that these results may not be comparable with studies that used the WHO 'other' category. Very few retreatment cases had their sputum samples received at the NTRL for culture and DST. More retreatment cases than have been reported here could have received culture and DST as part of a national drug resistance survey that partly overlapped the study period. Unfortunately, culture and DST information collected for that survey could not be accessed by the NTRL, as the NTRL staff was blinded to this information. The fi ndings of the number of cases that received culture and DST from the three hospitals may therefore have been underreported here. It will be important to perform a further analysis when the information on the survey is unblinded. In conclusion, management of TB retreatment cases in three regional referral hospitals in Uganda was weak and treatment success rates for all categories of cases were low (below 55%). Relapse smear-positive and treatment after failure patients were less likely to have a successful treatment outcome. Decentralising culture and DST services, adherence to international and national TB guidelines and strengthening the follow-up system for TB patients are recommended to improve the management of TB retreatment cases in Uganda.
Contexte : Trois hôpitaux régionaux de référence en Ouganda où le fardeau de la tuberculose (TB) et du virus de l'immunodéficience humaine (VIH) est élevé. Objectif : Déterminer les résultats du traitement de cas de retraitement de la TB et les caractéristiques qui ont une influence sur ces résultats. Schéma : Etude rétrospective de cohorte des données colligées en routine par le Programme National de Tuberculose entre le 1er janvier 2009 et le 31 décembre 2010. Résultats : On a étudié au total 331 patients en retraitement (68% d'hommes) d'un âge moyen de 36 ans. Il s'agissait chez 93 (28%) de rechutes à bacilloscopie positive, chez 21 (6%) d'un traitement après échec, chez 159 (48%) d'un retour après perte de vue, chez 26 (8%) d'une rechute à bacilloscopie négative et chez 32 (10%) d'une rechute sans contrôle du frottis. Les taux de succès du traitement pour toutes ces catégories de cas de retraitement ont varié entre 28% et 54%. Les cas de rechute à bacilloscopie positive (P = 0,002) et les traitements après échec (P = 0,038) ont été moins susceptibles de connaître un résultat de traitement couronné de succès. Le régime de traitement de Catégorie II n'a été administré qu'à 32% des cas de retraitement. On n'a pas noté de différences de succès du traitement entre les patients qui ont reçu les régimes de Catégorie II ou de Catégorie I (P = 0,73). Conclusion : La prise en charge des cas de retraitement de TB et les succès du traitement pour toutes les catégories ont été médiocres dans les trois hôpitaux de référence en Ouganda. Les cas les moins susceptibles de connaître un résultat de traitement couronné de succès sont les rechutes à bacilloscopie positive ou les cas de traitement après échec.
Marco de referencia:
Tres hospitales regionales de referencia en Uganda, un país donde existe una alta carga de morbilidad por tuberculosis (TB) e infección por el virus de la inmunodeficiencia humana (VIH). Objetivo: Analizar los desenlaces terapéuticos en los casos de retratamiento de la TB y determinar las características que influyen en estos desenlaces. Métodos: Se llevó a cabo un estudio retrospectivo de cohortes a partir de los datos recogidos de manera sistemática en el Programa Nacional contra la Tuberculosis entre el 1° de enero del 2009 y el 31 de diciembre del 2010.
Resultados: Se incluyeron en el estudio 331 pacientes en retratamiento (68% de sexo masculino) cuya mediana de la edad fue 36 años. Noventa y tres casos (28%) correspondieron a recaídas con baciloscopia positiva, 21 casos (6%) a fracaso terapéutico, 159 (48%) a recuperación tras pérdida durante el seguimiento, 26 (8%) a recaídas con baciloscopia negativa y 32 casos (10%) fueron recaídas sin estudio microscópico. Las tasas de éxito terapéutico en todas las catego rías de casos de retratamiento oscilaron entre 28% y 54%. Los casos de recaída con baciloscopia positiva (P = 0,002) y de retratamiento posterior a fracaso terapéutico (P = 0,038) exhibieron una menor probabilidad de lograr un tratamiento eficaz. Solo el 32% de los
